Update for the 2020/21 Invitation to Tender e-portal - 10 December 2020

Medicines

Tender Closed

We have made some amendments on the e-portal for the 2020/21 Invitation to Tender that was issued on 2 November 2020. 

 The following amendments have been uploaded to the e-portal.

Addition of line items

The following 2020/21 Invitation to Tender (ITT) Tender items failed to upload into the e-portal and have now been added to the In-tend e-portal for bidding:

  • Aciclovir – Eye oint 3%
  • Aciclovir – Inj 250 mg
  • Amoxicillin clavulanate – Inj 500 mg with clavulanic acid 100 mg
  • Amoxicillin clavulanate – Inj 1000 mg with clavulanic acid 200 mg
  • Brimonidine tartrate – Eye Drops 0.15% - 0.2%
  • Brimonidine tartrate with timolol maleate – Eye drops 0.2% with timolol maleate 0.5%
  • Dobutamine – Inj 40 mg per ml, 5 ml
  • Dopamine – Inj 40 mg per ml, 5 ml
  • Glycopyrronium bromide – Inj 0.2 mg per ml, 1 ml
  • Haloperidol decanoate – Inj 50 mg per ml, 1 ml
  • Haloperidol decanoate – Inj 100 mg per ml, 1 ml
  • Hydrogen Peroxide – Crm 1%
  • Hydrogen Peroxide – Crm 2%
  • Neostigmine metisulfate with glycopyrronium bromide – Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml
  • Olanzapine – Inj 210 mg
  • Olanzapine – Inj 300 mg
  • Olanzapine – Inj 405 mg
  • Risperidone – Inj 25 mg
  • Risperidone – Inj 37.5 mg
  • Risperidone – Inj 50 mg

More information

If you have any queries regarding the tender, please contact the tender analysts at tender@pharmac.govt.nz